Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Current Taxes (2023 - 2024)

Sutro Biopharma (STRO) has disclosed Current Taxes for 2 consecutive years, with $18000.0 as the latest value for Q4 2024.

  • Quarterly Current Taxes fell 99.88% to $18000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $18000.0 through Dec 2024, down 99.88% year-over-year, with the annual reading at $18000.0 for FY2024, 99.88% down from the prior year.
  • Current Taxes hit $18000.0 in Q4 2024 for Sutro Biopharma, roughly flat from $18000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $15.2 million in Q4 2023 to a low of $11000.0 in Q2 2024.